Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-1753
EMBO J 2005 Jul 06;2413:2318-30. doi: 10.1038/sj.emboj.7600715.
Show Gene links Show Anatomy links

Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.

Tammaro P , Girard C , Molnes J , Njølstad PR , Ashcroft FM .


???displayArticle.abstract???
ATP-sensitive K(+) (K(ATP)) channels, comprised of pore-forming Kir6.2 and regulatory SUR1 subunits, play a critical role in regulating insulin secretion. Binding of ATP to Kir6.2 inhibits, whereas interaction of MgATP with SUR1 activates, K(ATP) channels. We tested the functional effects of two Kir6.2 mutations (Y330C, F333I) that cause permanent neonatal diabetes mellitus, by heterologous expression in Xenopus oocytes. Both mutations reduced ATP inhibition and increased whole-cell currents, which in pancreatic beta-cells is expected to reduce insulin secretion and precipitate diabetes. The Y330C mutation reduced ATP inhibition both directly, by impairing ATP binding (and/or transduction), and indirectly, by stabilizing the intrinsic open state of the channel. The F333I mutation altered ATP binding/transduction directly. Both mutations also altered Kir6.2/SUR1 interactions, enhancing the stimulatory effect of MgATP (which is mediated via SUR1). This effect was particularly dramatic for the Kir6.2-F333I mutation, and was abolished by SUR1 mutations that prevent MgATP binding/hydrolysis. Further analysis of F333I heterozygous channels indicated that at least three SUR1 must bind/hydrolyse MgATP to open the mutant K(ATP) channel.

???displayArticle.pubmedLink??? 15962003
???displayArticle.pmcLink??? PMC1173155
???displayArticle.link??? EMBO J
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: abcc8 ins kcnj11

References [+] :
Aguilar-Bryan, Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. 1995, Pubmed